InsiderClue
← All stocks

Avantor, Inc.

AVTR Net selling
CIK 0001722482 #954 in the set updated 17 Sep 2026
Bought (120 mo)
$27.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.21B
$621.18K on a plan · $74.74M straight out of an exercise
Sold at will
$3.14B
106 of 150 sales
Net
−$3.19B
−$3.11B against sales at will

By person

48 insiders · 221 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
New Mountain Investments III, LLC entity
10% owner
—
$1.72B (4)
−$1.72B
28,000,000
4.14%
$232.96M
−74.7%
Natauri Jo
Director
$5.25M (16)
$604.43M (18)
−$599.18M
650,317
0.0961%
$5.41M
—
GOLDMAN SACHS & CO. LLC entity
10% owner
$5.24M (15)
$523.85M (17)
−$518.60M
43,483,708
6.43%
$361.78M
+1,595,632%
Connolly Thomas
Director
$5.24M (15)
$223.50M (16)
−$218.26M
58,881,710
8.71%
$489.90M
+1,581,891%
GUPTA RAJIV
Director
—
$40.17M (10)
−$40.17M
1,058,671
0.1565%
$8.81M
+138.1%
Stubblefield Michael
President & CEO
$314.25K (1)
$35.52M (7) scheduled
−$35.20M
1,764,513
0.2609%
$14.68M
—
Brophy Gerard
EVP, Biopharma Production
—
$22.19M (17) scheduled
−$22.19M
89,032
0.0132%
$740.75K
—
Ohri Devashish
EVP, IMEA
—
$14.51M (13) scheduled
−$14.51M
139,095
0.0206%
$1.16M
—
Vanderhaegen Frederic
EVP, Americas and Europe
—
$8.31M (7)
−$8.31M
160,735
0.0238%
$1.34M
+5,380%
Couturier Christophe
EVP, AMEA
—
$6.71M (14) scheduled
−$6.71M
211,271
0.0312%
$1.76M
+3,758%
MEHRA SANJEEV K
Director
$4.88M (2)
—
+$4.88M
508,376
0.0752%
$4.23M
—
SUMME GREGORY L
Director
$4.56M (7)
—
+$4.56M
483,381
0.0715%
$4.02M
—
Miller Justin
EVP & General Counsel
—
$4.47M (4) scheduled
−$4.47M
93,336
0.0138%
$776.56K
+3,290%
Wondrasch Michael
EVP & CIO
—
$2.55M (5) scheduled
−$2.55M
96,072
0.0142%
$799.32K
—
Bramwell James
EVP Sales, Customer Excellence
—
$1.66M (10)
−$1.66M
86,605
0.0128%
$720.55K
+754.3%
Eck Steven W
SVP & Chief Accounting Officer
—
$1.18M (7)
−$1.18M
129,593
0.0192%
$1.08M
+592.0%
Ligner Emmanuel
President and CEO
$993.13K (1)
—
+$993.13K
737,334
0.1090%
$6.13M
—
LUCIER GREGORY T
Director
$541.20K (2)
—
+$541.20K
94,006
0.0139%
$782.13K
—
Shaw Christi
Director
—
$381.15K (1)
−$381.15K
36,271
0.0054%
$301.77K
—
Szlosek Thomas A
EVP & CFO
$258.85K (1)
—
+$258.85K
113,157
0.0167%
$941.47K
—
Dingemans Simon
Director
$203.50K (1)
—
+$203.50K
56,495
0.0084%
$470.04K
—
Peacock Jonathan M
Director
$103.65K (1)
—
+$103.65K
219,815
0.0325%
$1.83M
+1,140%
Massaro Joseph R
Director
$99.63K (1)
—
+$99.63K
77,408
0.0114%
$644.03K
—
Kang Lan
Director
$62.85K (1)
—
+$62.85K
52,315
0.0077%
$435.26K
—
Jones R. Brent
EVP, Chief Financial Officer
—
—
—
419,782
0.0621%
$3.49M
+18,328%
Walker Corey
President, VWR Dist. & Servs.
—
—
—
384,535
0.0569%
$3.20M
—
Gourdier Benoit
EVP, Bioscience & Medtech
—
—
—
362,859
0.0536%
$3.02M
—
Blenn Mary
EVP, Chief Operating Officer
—
—
—
253,384
0.0375%
$2.11M
—
Sokenu Claudius
EVP, Chief Legal & Compliance
—
—
—
251,228
0.0371%
$2.09M
—
Hankamer Brittany
EVP, Chief HR Officer
—
—
—
248,864
0.0368%
$2.07M
+876.0%
McAllister Eric
EVP, CHRO
—
—
—
197,899
0.0293%
$1.65M
+180.8%
Hofman Bjorn
EVP and COO
—
—
—
157,143
0.0232%
$1.31M
—
Brellier Ludovic
EVP, Bioscience & Medtech
—
—
—
146,566
0.0217%
$1.22M
—
Kulkarni Ashish
See Remarks
—
—
—
128,571
0.0190%
$1.07M
—
SEVERINO MICHAEL
Director
—
—
—
85,821
0.0127%
$714.03K
—
Lewis Sheri
EVP, Global Ops & Supply Chain
—
—
—
70,692
0.0105%
$588.16K
+2,356,300%
Murthy Mala
Director
—
—
—
69,479
0.0103%
$578.07K
—
Stone Randy Lee
EVP, Laboratory Solutions
—
—
—
68,105
0.0101%
$566.63K
+7,746%
Andres Juan
Director
—
—
—
65,480
0.0097%
$544.79K
+1,703%
Makin Louise
Director
—
—
—
47,140
0.0070%
$392.20K
—
Carethers John
Director
—
—
—
45,858
0.0068%
$381.54K
—
Sahin Kitty
EVP, Strategy&Corp Development
—
—
—
42,274
0.0063%
$351.72K
+58.4%
Henson Meghan
EVP, Chief HR Officer
—
—
—
40,184
0.0059%
$334.33K
—
Foxe Tanya
EVP, Operations & Supply Chain
—
—
—
39,458
0.0058%
$328.29K
—
SACHDEV RAKESH
Director
—
—
—
32,841
0.0049%
$273.24K
—
Henrichwark Sven
EVP, APAC Region
—
—
—
19,802
0.0029%
$164.75K
—
Murray Mark Christopher
EVP, Biomaterials & AT
—
—
—
18,680
0.0028%
$155.42K
—
Holt Matthew S.
Director
—
—
—
7,908
0.0012%
$65.79K
—

Individual transactions

106
Insider
Date
Role
Action
Shares
Price
Amount
Eck Steven W
5 Sep 2024
SVP & Chief Accounting Officer
Sell
3,525
$25.06
$88.34K
Couturier Christophe
29 Feb 2024
EVP, AMEA
Sell
13,074
$24.53
$320.71K
Bramwell James
29 Feb 2024
EVP Sales, Customer Excellence
Sell
4,910
$24.52
$120.39K
Bramwell James
27 Feb 2024
EVP Sales, Customer Excellence
Sell
6,203
$24.49
$151.91K
Eck Steven W
7 Sep 2023
SVP & Chief Accounting Officer
Sell
7,577
$20.64
$156.39K
Vanderhaegen Frederic
25 Aug 2023
EVP, Americas and Europe
Sell
25,000
$21.47
$536.75K
Brophy Gerard
3 Mar 2023
EVP, Biopharma Production
Sell
3,914
$25.00
$97.85K
Couturier Christophe
28 Feb 2023
EVP, AMEA
Sell
2,324
$24.32
$56.52K
Brophy Gerard
27 Feb 2023
EVP, Biopharma Production
Sell
3,059
$25.00
$76.48K
Couturier Christophe
23 Feb 2023
EVP, AMEA
Sell
3,078
$24.24
$74.61K
Couturier Christophe
22 Feb 2023
EVP, AMEA
Sell
19,160
$24.12
$462.14K
Brophy Gerard
2 Feb 2023
EVP, Biopharma Production
Sell
11,339
$25.06
$284.16K
Vanderhaegen Frederic
23 May 2022
EVP, Americas & Europe
Sell
39,000
$31.61
$1.23M
Brophy Gerard
20 May 2022
EVP, Biopharma Production
Sell
19,603
$31.27
$612.99K
Brophy Gerard
1 Mar 2022
EVP, Biopharma Production
Sell
2,027
$34.47
$69.87K
Brophy Gerard
23 Feb 2022
EVP, Biopharma Production
Sell
3,059
$33.79
$103.36K
Brophy Gerard
5 Jan 2022
EVP, Biopharma Production
Sell
11,551
$38.65
$446.45K
GUPTA RAJIV
1 Dec 2021
Director
Sell
100,000
$39.30
$3.93M
Vanderhaegen Frederic
11 Nov 2021
EVP, Europe
Sell
60,804
$38.41
$2.34M
GUPTA RAJIV
1 Nov 2021
Director
Sell
100,000
$40.31
$4.03M
GUPTA RAJIV
1 Oct 2021
Director
Sell
100,000
$39.94
$3.99M
Stubblefield Michael
20 Sep 2021
President and CEO
Sell
141,300
$42.37
$5.99M
GUPTA RAJIV
1 Sep 2021
Director
Sell
100,000
$39.45
$3.95M
Eck Steven W
26 Aug 2021
SVP & Chief Accounting Officer
Sell
17,383
$40.08
$696.71K
GUPTA RAJIV
20 Aug 2021
Director
Sell
100,000
$38.81
$3.88M
Bramwell James
20 Jul 2021
EVP, Strategic Partners
Sell
6,112
$37.00
$226.14K
Bramwell James
9 Jul 2021
EVP, Strategic Partners
Sell
12,221
$35.64
$435.56K
Bramwell James
9 Jul 2021
EVP, Strategic Partners
Sell
6,110
$35.56
$217.27K
Couturier Christophe
28 Jun 2021
EVP, AMEA
Sell
28,096
$35.73
$1.00M
GUPTA RAJIV
25 Jun 2021
Director
Sell
68,605
$35.32
$2.42M
GUPTA RAJIV
27 May 2021
Director
Sell indirect
78,109
$31.94
$2.49M
GUPTA RAJIV
26 May 2021
Director
Sell indirect
150,000
$31.89
$4.78M
GUPTA RAJIV
24 May 2021
Director
Sell indirect
157,571
$31.57
$4.97M
GUPTA RAJIV
24 May 2021
Director
Sell indirect
180,000
$31.74
$5.71M
Wondrasch Michael
21 May 2021
EVP & CIO
Sell
18,488
$31.41
$580.71K
Brophy Gerard
20 May 2021
EVP, Biopharma Production
Sell
19,603
$31.10
$609.65K
Couturier Christophe
20 May 2021
EVP, AMEA
Sell
25,010
$31.13
$778.56K
Miller Justin
20 May 2021
EVP & General Counsel
Sell
18,488
$31.12
$575.35K
Natauri Jo
11 May 2021
Director
Sell indirect
2,626,771
$30.68
$80.59M
Bramwell James
12 Apr 2021
EVP, Strategic Partners
Sell
2,505
$32.00
$80.16K
Vanderhaegen Frederic
12 Apr 2021
EVP, Europe
Sell
17,075
$31.83
$543.50K
Vanderhaegen Frederic
12 Apr 2021
EVP, Europe
Sell
10,000
$31.75
$317.50K
Vanderhaegen Frederic
9 Mar 2021
EVP, Europe
Sell
10,000
$28.21
$282.10K
Wondrasch Michael
2 Mar 2021
EVP & CIO
Sell
3,036
$28.71
$87.16K
Brophy Gerard
24 Feb 2021
EVP, Biopharma Production
Sell
3,059
$27.93
$85.44K
Bramwell James
11 Jan 2021
EVP, Strategic Partners
Sell
2,505
$30.00
$75.15K
Brophy Gerard
6 Jan 2021
EVP, Biopharma Production
Sell
11,509
$27.24
$313.51K
Bramwell James
21 Dec 2020
EVP, Strategic Partners
Sell
10,020
$27.14
$271.94K
Shaw Christi
11 Dec 2020
Director
Sell
14,286
$26.68
$381.15K
New Mountain Investments III, LLC
10 Nov 2020
10% owner
Sell indirect
36,016,093
$24.81
$893.49M
Miller Justin
8 Sep 2020
EVP & General Counsel
Sell
22,887
$21.17
$484.52K
New Mountain Investments III, LLC
21 Aug 2020
10% owner
Sell indirect
25,575,472
$19.51
$498.89M
GOLDMAN SACHS & CO. LLC
21 Aug 2020
10% owner
Sell indirect
15,397,005
$19.51
$300.34M
Natauri Jo
21 Aug 2020
Director
Sell indirect
15,397,005
$19.51
$300.34M
GOLDMAN SACHS & CO. LLC
26 May 2020
10% owner
Sell indirect
13,726,411
$15.90
$218.25M
Connolly Thomas
26 May 2020
Director
Sell indirect
13,726,411
$15.90
$218.25M
Natauri Jo
26 May 2020
Director
Sell indirect
13,726,411
$15.90
$218.25M
New Mountain Investments III, LLC
26 May 2020
10% owner
Sell indirect
20,886,424
$15.90
$332.19M
Wondrasch Michael
22 May 2020
EVP & CIO
Sell
22,987
$17.82
$409.63K
Brophy Gerard
20 May 2020
EVP, Biopharma Production
Sell
25,495
$17.36
$442.59K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
9,922
$14.80
$146.85K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
5,164
$14.79
$76.38K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
100
$14.79
$1.48K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
3,800
$14.78
$56.16K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
100
$14.78
$1.48K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
4,146
$14.76
$61.19K
Connolly Thomas
25 Sep 2019
Director
Sell indirect
1,768
$14.70
$25.99K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
9,922
$14.80
$146.85K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
5,164
$14.79
$76.38K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
100
$14.79
$1.48K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
3,800
$14.78
$56.16K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
100
$14.78
$1.48K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
4,146
$14.76
$61.19K
GOLDMAN SACHS & CO. LLC
25 Sep 2019
10% owner
Sell indirect
1,768
$14.70
$25.99K
Natauri Jo
25 Sep 2019
Director
Sell indirect
9,922
$14.80
$146.85K
Natauri Jo
25 Sep 2019
Director
Sell indirect
5,164
$14.79
$76.38K
Natauri Jo
25 Sep 2019
Director
Sell indirect
100
$14.79
$1.48K
Natauri Jo
25 Sep 2019
Director
Sell indirect
3,800
$14.78
$56.16K
Natauri Jo
25 Sep 2019
Director
Sell indirect
100
$14.78
$1.48K
Natauri Jo
25 Sep 2019
Director
Sell indirect
4,146
$14.76
$61.19K
Natauri Jo
25 Sep 2019
Director
Sell indirect
1,768
$14.70
$25.99K
Connolly Thomas
9 Sep 2019
Director
Sell indirect
149,694
$16.46
$2.46M
GOLDMAN SACHS & CO. LLC
9 Sep 2019
10% owner
Sell indirect
149,694
$16.46
$2.46M
Natauri Jo
9 Sep 2019
Director
Sell indirect
149,694
$16.46
$2.46M
Connolly Thomas
6 Sep 2019
Director
Sell indirect
49,200
$17.06
$839.54K
Connolly Thomas
6 Sep 2019
Director
Sell indirect
67,437
$16.51
$1.11M
GOLDMAN SACHS & CO. LLC
6 Sep 2019
10% owner
Sell indirect
49,200
$17.06
$839.54K
GOLDMAN SACHS & CO. LLC
6 Sep 2019
10% owner
Sell indirect
67,437
$16.51
$1.11M
Natauri Jo
6 Sep 2019
Director
Sell indirect
49,200
$17.06
$839.54K
Natauri Jo
6 Sep 2019
Director
Sell indirect
67,437
$16.51
$1.11M
Connolly Thomas
12 Aug 2019
Director
Sell indirect
9
$16.66
$149.94
Connolly Thomas
12 Aug 2019
Director
Sell indirect
16,245
$16.51
$268.26K
GOLDMAN SACHS & CO. LLC
12 Aug 2019
10% owner
Sell indirect
9
$16.66
$149.94
GOLDMAN SACHS & CO. LLC
12 Aug 2019
10% owner
Sell indirect
16,245
$16.51
$268.26K
Natauri Jo
12 Aug 2019
Director
Sell indirect
9
$16.66
$149.94
Natauri Jo
12 Aug 2019
Director
Sell indirect
16,245
$16.51
$268.26K
Connolly Thomas
6 Aug 2019
Director
Sell indirect
88
$16.66
$1.47K
GOLDMAN SACHS & CO. LLC
6 Aug 2019
10% owner
Sell indirect
88
$16.66
$1.47K
Natauri Jo
6 Aug 2019
Director
Sell indirect
88
$16.66
$1.47K
Connolly Thomas
31 Jul 2019
Director
Sell indirect
55
$17.55
$965.12
GOLDMAN SACHS & CO. LLC
31 Jul 2019
10% owner
Sell indirect
55
$17.55
$965.12
Natauri Jo
31 Jul 2019
Director
Sell indirect
55
$17.55
$965.12
New Mountain Investments III, LLC
21 May 2019
10% owner
Sell indirect
100
$14.00
$1.40K
Connolly Thomas
17 May 2019
Director
Sell indirect
14,049
$14.00
$196.69K
GOLDMAN SACHS & CO. LLC
17 May 2019
10% owner
Sell indirect
14,049
$14.00
$196.69K
Natauri Jo
17 May 2019
Director
Sell indirect
14,049
$14.00
$196.69K
Show all 221 transactions →

What was left out

Form 4 filings counted 434
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 35
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 259,237,468
Sales filed before the plan box existed 100
History held since 23 May 2019